Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02088 |
| Species: | Mus musculus |
| Position : | chr3:103470000-103520000 |
| Year: | 2026 |
| Title: | YAP/TAZ-VGLL3 governs adipocyte fate via epigenetic reprogramming of PPAR?? and its target enhancers |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 41533786 |
| MONDO: | |
| Tissue: | Adipose tissue |
| Tissue Ontology ID: | UBERON:0001013 |
| Cell Source: | C3H10T1/2, primary adipocytes |
| CVCL ID: | CVCL_0190 |
| Cell Type: | mesenchymal cell / adipocyte |
| Cell Ontology ID: | CL:0000136 |
| Experiment Type: | Regulatory element functional validation, 3D chromatin architecture analysis, epigenomic profiling |
| High Throughput Method: | ATAC-seq, RNA-seq, ChIP-seq, snRNA-seq, snATAC-seq |
| Low Throughput Method: | CRISPRi (dCas9-KRAB-MeCP2), RT-RT-qPCR, ORCA, Western blot, Oil Red O staining |
| Target gene : | Pparg |
| TF name : | Tead |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|